Mood support lozenges sales will expand through 2036, with supermarkets/hypermarkets at 39.6% within the distribution channel segment, mood balance at 33.8% of the benefit category and lozenges at 36.4% of product type demand in 2026. The market is projected to record an 11.9% CAGR between 2026 and 2036.